[1] Veerbsky J W, Grossman W J. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives[J].Ann Med, 2006,38: 20-31.[2] Janka G E. Familial and acquired hemophagocytic lymphohistiocytosis[J]. Eur J Pediatr,2007,166(2): 95-109.[3] 王旖旎, 王昭, 吴林,等. 多中心72例噬血细胞综合征诊疗分析[J]. 中华血液学杂志,2009,30(12): 793-798.[4] Imran MN, Leng PH, Yang S, et al. Early predictors of mortality in pneumococcal bacteraemia[J].Ann Acad Med Singapore,2005,34(7):426-431.[5] 蔡大利,高峰,高然,等.异基因外周血造血干细胞联合骨髓移植治疗重型再生障碍性贫血4例报告[J]. 中国医科大学学报,2013,42(4):379-381.[6] 陈惠仁. 血液科造血干细胞移植技术新进展与发展设想[J]. 解放军医药杂志,2013,25(4):1-5.[7] 赵卫红. 细胞凋亡的生物学特征. 见赵卫红,寿好长,闫福岭,等主编. 细胞凋亡[M]. 郑州: 河南医科大学出版社,1997,7-11.[8] Welsh J P, Rutherford T R, Flynn J, et al. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+bone marrow progenitor cells from aplastic anemia patients and normal donors[J]. Hematol J, 2004,5(1):39-46.[9] Dai C, Krantz S B. Interferon-γ induces upregulation and activetion of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells[J]. Blood, 1999, 93(10): 3309-3316.[10] Platanias L C. Mechanisms of type-Ⅰ- and type- Ⅱ -interferon-mediated signalling[J]. Nat Rev Immunol, 2005,5(5):375-386.[11] Chatterjee S, Dutta R K, Basak P, et al. Alteration in marrow stromal microenvironment and apoptosis mechanisms involved in aplastic anemia:an animal model to study the possible disease pathology[J]. Stem Cells Int, 2010,2010:932354.[12] 陈勤,汤屹,孟力.骨髓呈再生障碍性贫血样表现的低增生性白血病[J]. 临床误诊误治,2012,25(1):11-14.[13] Wang Y, Wang Z, Wu L, et al. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis[J].Ann Hematol, 2013,92(12):1695-1699. |